Published on 27 June 2016
Switching from the infliximab reference product to CT-P13 in patients with rheumatoid arthritis or ankylosing spondylitis: results of the PLANETAS and PLANETRA extension studies
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2016.0502.023
13.303 views